ARKG
ARKG
About ARK Genomic Revolution ETF
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.
About ARK Genomic Revolution ETF
ARKG is an actively managed Exchange Traded Fund (ETF) that seeks long-term growth of capital by investing under normal circumstances primarily (at least 80% of its assets) in domestic and foreign equity securities of companies across multiple sectors that are relevant to the Fund’s investment theme of the genomics revolution.
HOLDINGS (Top 20)
| Stock | Name | Weight | Shares | Market Value |
|---|---|---|---|---|
 CRSP | CRISPR Therapeutics AG | 10.02% | 2.14M | $132.10M |
 TEM | Tempus AI, Inc. | 8.42% | 2.00M | $111.04M |
 TWST | Twist Bioscience Corporation | 8.02% | 2.17M | $105.70M |
 PSNL | Personalis, Inc. | 5.90% | 8.61M | $77.73M |
 TXG | 10x Genomics, Inc. | 5.70% | 3.40M | $75.21M |
 BEAM | Beam Therapeutics Inc. | 5.10% | 2.32M | $67.17M |
 GH | Guardant Health, Inc. | 4.25% | 571.98K | $56.04M |
 RXRX | Recursion Pharmaceuticals, Inc. | 3.75% | 13.13M | $49.48M |
 NTLA | Intellia Therapeutics, Inc. | 3.38% | 3.12M | $44.52M |
 VCYT | Veracyte, Inc. | 3.33% | 1.13M | $43.95M |
 CDNA | CareDx, Inc | 3.31% | 2.32M | $43.59M |
 ADPT | Adaptive Biotechnologies Corporation | 2.77% | 2.22M | $36.56M |
 SDGR | Schrödinger, Inc. | 2.12% | 2.19M | $27.94M |
 NRIX | Nurix Therapeutics, Inc. | 2.01% | 1.65M | $26.51M |
 WGS | GeneDx Holdings Corp. | 1.73% | 280.61K | $22.84M |
 PRME | Prime Medicine, Inc. | 1.71% | 5.15M | $22.57M |
 ARCT | Arcturus Therapeutics Holdings Inc. | 1.70% | 2.70M | $22.47M |
 CMPS | COMPASS Pathways plc | 1.68% | 3.02M | $22.12M |
 PACB | Pacific Biosciences of California, Inc. | 1.55% | 11.51M | $20.49M |
 MASS | 908 Devices Inc. | 1.08% | 2.04M | $14.21M |
SECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States
Switzerland
United KingdomSECTOR HOLDINGS
HealthcareASSET ALLOCATION BY REGION
United States Switzerland United KingdomHoldings (Top 20)
CRSP
CRISPR Therapeutics AG
TEM
Tempus AI, Inc.
TWST
Twist Bioscience Corporation
PSNL
Personalis, Inc.
TXG
10x Genomics, Inc.
BEAM
Beam Therapeutics Inc.
GH
Guardant Health, Inc.
RXRX
Recursion Pharmaceuticals, Inc.
NTLA
Intellia Therapeutics, Inc.
VCYT
Veracyte, Inc.
CDNA
CareDx, Inc
ADPT
Adaptive Biotechnologies Corporation
SDGR
Schrödinger, Inc.
NRIX
Nurix Therapeutics, Inc.
WGS
GeneDx Holdings Corp.
PRME
Prime Medicine, Inc.
ARCT
Arcturus Therapeutics Holdings Inc.
CMPS
COMPASS Pathways plc
PACB
Pacific Biosciences of California, Inc.
MASS
908 Devices Inc.